Competing Statement Declarations
DB and SA have received compensation for consultancies, presentations and advisory board activities but no companies were involved in the decision to write and submit this manuscript. LFB has nothing to disclose. SA has received consultancy from Novartis and Roche. DB has received compensation for activities related to Canbex therapeutics, InMune Biol, Lundbeck, Japan tobacco, Merck, Novartis.